← Back to Analyst Consensus 
NVCR Buy
NovoCure Ltd
Current Price —
Implied Upside —
Analysts 13
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Oct 29, 2026 (2 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Jul 24, 2026 | Wedbush | maintain | Neutral → Neutral | — | 57% |
| Jul 23, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Jun 18, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| May 4, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| May 1, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| Apr 16, 2026 | Wedbush | reiterate | Neutral → Neutral | — | 57% |
| Feb 26, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | $49 | 44% |
| Feb 12, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | $47 | 44% |
| Jan 15, 2026 | Wedbush | reiterate | Neutral → Neutral | $18 | 57% |
| Jan 13, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | $39 | 44% |
| Oct 30, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $42 | 44% |
| Oct 27, 2025 | JP Morgan | maintain | Neutral → Neutral | $23 | 54% |
| Jul 25, 2025 | Wells Fargo | downgrade | Overweight → Equal-Weight | $14.5 | 54% |
| Jul 8, 2025 | Ladenburg Thalmann | initiate | — → Buy | $30 | 45% |
| Jun 27, 2025 | Piper Sandler | reiterate | Overweight → Overweight | $34 | 54% |
| Apr 23, 2025 | Piper Sandler | maintain | Overweight → Overweight | $34 | 54% |
| Apr 16, 2025 | Wedbush | maintain | Neutral → Neutral | $27 | 57% |
| Apr 10, 2025 | JP Morgan | maintain | Neutral → Neutral | $28 | 54% |
| Jan 14, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $38 | 44% |
| Dec 13, 2024 | Piper Sandler | maintain | Overweight → Overweight | $42 | 54% |
| Dec 3, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $38 | 44% |
| Dec 2, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $38 | 44% |
| Dec 2, 2024 | Evercore ISI Group | upgrade | In-Line → Outperform | $30 | 58% |
| Nov 21, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $30 | 44% |
| Oct 31, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $30 | 44% |
| Oct 16, 2024 | HC Wainwright & Co. | upgrade | Neutral → Buy | $30 | 44% |
| Oct 1, 2024 | Evercore ISI Group | maintain | In-Line → In-Line | $18 | 58% |
| Jul 26, 2024 | Wells Fargo | maintain | Overweight → Overweight | $40 | 54% |
| Jul 26, 2024 | HC Wainwright & Co. | maintain | Neutral → Neutral | $24 | 44% |
| Jul 2, 2024 | Evercore ISI Group | maintain | In-Line → In-Line | $20 | 58% |
| Jun 4, 2024 | HC Wainwright & Co. | reiterate | Neutral → Neutral | $22 | 44% |
| May 2, 2024 | HC Wainwright & Co. | maintain | Neutral → Neutral | $22 | 44% |
| Apr 10, 2024 | Piper Sandler | reiterate | Overweight → Overweight | $28 | 54% |
| Apr 3, 2024 | Wells Fargo | maintain | Overweight → Overweight | $42 | 54% |
| Mar 27, 2024 | HC Wainwright & Co. | maintain | Neutral → Neutral | $24 | 44% |
| Mar 19, 2024 | JP Morgan | maintain | Neutral → Neutral | $17 | 54% |
| Mar 12, 2024 | HC Wainwright & Co. | reiterate | Neutral → Neutral | $22 | 44% |
| Feb 23, 2024 | Evercore ISI Group | maintain | In-Line → In-Line | $15 | 58% |
| Feb 22, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $22 | 44% |
| Aug 29, 2023 | Wells Fargo | maintain | Overweight → Overweight | $49 | 54% |
| Aug 28, 2023 | HC Wainwright & Co. | downgrade | Buy → Neutral | $25 | 44% |
| Aug 8, 2023 | Piper Sandler | upgrade | Neutral → Overweight | $45 | 54% |
| Aug 4, 2023 | SVB Leerink | initiate | — → Outperform | $51 | — |
| Jul 31, 2023 | Evercore ISI Group | upgrade | Underperform → In-Line | $33 | 58% |
| Jul 28, 2023 | Wells Fargo | maintain | Overweight → Overweight | $102 | 54% |
| Jul 27, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $85 | 44% |
| Jun 7, 2023 | Piper Sandler | maintain | Neutral → Neutral | $62 | 54% |
| Jun 7, 2023 | Wedbush | upgrade | Underperform → Neutral | $46 | 57% |
| Jun 6, 2023 | Truist Securities | reiterate | Buy → Buy | $95 | 54% |
| Jun 6, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $115 | 44% |
Price Target Trend
Apr 28, 2026 Latest: $26.86 Oct 24, 2026
EPS Estimates
+1y $-0.81
Lo: $-1.26 Hi: $-0.22
7 analysts ▲1
0q $-0.23
Lo: $-0.31 Hi: $-0.14
7 analysts ▲1
0y $-1.24
Lo: $-1.37 Hi: $-1.05
7 analysts ▲1
+1q $-0.24
Lo: $-0.31 Hi: $-0.15
6 analysts ▲5
Cross-Platform Signals
No cross-platform signals in the last 90 days